Why the study?
Does the control of blood pressure and serum cholesterol levels reduce cardiovascular disease morbidity in treated, middle-aged hypertensive men?
Does the control of blood pressure and serum cholesterol levels reduce cardiovascular disease morbidity in treated, middle-aged hypertensive men?
Combined reduction of both blood pressure and serum cholesterol is necessary to substantially reduce CVD morbidity in treated hypertensive men, with a potential J-curve effect for BP reduction.
Answers are grounded in this paper and cite their sources.
Supports dual risk-factor control in treated hypertensives; leaves open optimal targets and causality pending randomized trials.
The relationship of cardiovascular disease (CVD) to the control of blood pressure (BP) and serum cholesterol levels was studied in 686 treated, middle-aged hypertensive men whose condition was followed up for 12 years. Both mean in-study BP (P<.001) and serum cholesterol levels (P<.001) were better predictors for CVD than the respective entry levels (both not significant) in multivariate analysis. Surprisingly, for mean in-study systolic and diastolic BP there seemed to be a level (approximately 150 and 85 mm Hg, respectively) below which further reduction of BP had no additional benefit from treatment. Analyses of CVD morbidity in relationship to changes in BP and serum cholesterol levels clearly showed that a combined reduction of both risk factors was necessary to achieve a substantial reduction in morbidity. These study findings indicate that (1) it may be unfavorable to reduce BP below a certain level in middle-aged hypertensive men; and (2) other risk factor interventions must be improved to improve the patient's prognosis. (JAMA1987;258:1768-1776)
No takes yet. Share an insight, caveat, or question.
O. Samuelsson (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: